title: [Intravenous thrombolytic therapy in acute infarct of the myocardium].
abstract: Treatment of acute myocardial infarction with plasminogen activators represents a significant advance in cardiovascular pharmacotherapy. This paper describes the first local treatment experience of myocardial infarction in two patients with intravenous thrombolytic agents. The indications and general aspects of thrombolytic treatment are discussed. Thrombolytic therapy has become standard treatment for some patients with acute myocardial infarction.
authors.forename: P
authors.initials: P
authors.lastname: Núñez
authors.forename: J
authors.initials: J
authors.lastname: Motta
authors.forename: A
authors.initials: A
authors.lastname: Arrocha
authors.forename: V
authors.initials: V
authors.lastname: Soto
mesh_terms: D000328:Adult; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator
vernacular_title: Terapia trombolítica intravenosa en el infarto agudo del miocardio.